PT73284A - Procede de preparation de derives de cephalosporines sulfoxides - Google Patents

Procede de preparation de derives de cephalosporines sulfoxides

Info

Publication number
PT73284A
PT73284A PT73284A PT7328481A PT73284A PT 73284 A PT73284 A PT 73284A PT 73284 A PT73284 A PT 73284A PT 7328481 A PT7328481 A PT 7328481A PT 73284 A PT73284 A PT 73284A
Authority
PT
Portugal
Prior art keywords
sulfoxide
preparation
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
PT73284A
Other languages
English (en)
French (fr)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8014512A external-priority patent/FR2485540A1/fr
Priority claimed from FR8104243A external-priority patent/FR2501209B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PT73284A publication Critical patent/PT73284A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT73284A 1980-06-30 1981-06-29 Procede de preparation de derives de cephalosporines sulfoxides PT73284A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8014512A FR2485540A1 (fr) 1980-06-30 1980-06-30 Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant
FR8104242 1981-03-03
FR8104243A FR2501209B1 (fr) 1981-03-03 1981-03-03 Nouveaux derives des cephalosporines et medicaments antibiotiques contenant lesdits derives

Publications (1)

Publication Number Publication Date
PT73284A true PT73284A (fr) 1981-07-01

Family

ID=27251008

Family Applications (2)

Application Number Title Priority Date Filing Date
PT73284A PT73284A (fr) 1980-06-30 1981-06-29 Procede de preparation de derives de cephalosporines sulfoxides
PT73283A PT73283B (fr) 1980-06-30 1981-06-29 Procede de preparation d'oxides de cephalosporines

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT73283A PT73283B (fr) 1980-06-30 1981-06-29 Procede de preparation d'oxides de cephalosporines

Country Status (12)

Country Link
US (1) US4604387A (pt)
EP (2) EP0043756B1 (pt)
AU (1) AU543165B2 (pt)
CA (2) CA1173434A (pt)
DE (2) DE3163490D1 (pt)
DK (2) DK283281A (pt)
ES (2) ES503562A0 (pt)
GR (2) GR75706B (pt)
IE (2) IE51359B1 (pt)
NO (2) NO159798C (pt)
NZ (2) NZ197563A (pt)
PT (2) PT73284A (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570702B1 (fr) * 1984-09-27 1987-01-09 Sanofi Sa Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
US5159077A (en) * 1989-07-21 1992-10-27 Hoffmann-La Roche Inc. Penam antibacterial compounds
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
US4200745A (en) * 1977-12-20 1980-04-29 Eli Lilly And Company 7[2-(2-Aminothiazol-4-yl)-2-alkoxyimino]acetamido 3[4-alkyl-5-oxo-6-hydroxy-3,4 dihydro 1,2,4-triazin 3-yl]thio methyl cephalosporins
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
US4349672A (en) * 1979-11-29 1982-09-14 Hoffmann-La Roche Inc. Cephalosporin derivatives

Also Published As

Publication number Publication date
EP0044238B1 (fr) 1984-02-01
NO812215L (no) 1982-01-04
NO159798B (no) 1988-10-31
NO159798C (no) 1989-02-08
ES8204996A1 (es) 1982-05-16
GR75706B (pt) 1984-08-02
IE811453L (en) 1981-12-30
DE3163490D1 (en) 1984-06-14
DK283281A (da) 1981-12-31
DK283381A (da) 1981-12-31
EP0043756B1 (fr) 1984-05-09
IE51359B1 (en) 1986-12-10
GR75711B (pt) 1984-08-02
PT73283B (fr) 1984-11-19
NZ197564A (en) 1983-12-16
NO812214L (no) 1982-01-04
NZ197563A (en) 1983-11-30
DE3162109D1 (en) 1984-03-08
US4604387A (en) 1986-08-05
EP0043756A1 (fr) 1982-01-13
ES503562A0 (es) 1982-05-16
ES503563A0 (es) 1982-04-01
PT73283A (fr) 1981-07-01
AU7241181A (en) 1982-01-07
CA1173434A (en) 1984-08-28
EP0044238A1 (fr) 1982-01-20
AU543165B2 (en) 1985-04-04
CA1175806A (en) 1984-10-09
IE811452L (en) 1981-12-30
ES8203384A1 (es) 1982-04-01
IE51358B1 (en) 1986-12-10

Similar Documents

Publication Publication Date Title
PT67906A (fr) Procede pour la preparation de derives de cephem.
MA20110A1 (fr) Procede de preparation de derives du cepheme.
MA20250A1 (fr) Procede de preparation de derives de cephalosporine.
BE876538A (fr) Procede de preparation de cephalosporines
RO82962A (ro) Procedeu pentru prepararea unor derivati de cefalosporina
MC1527A1 (fr) Procede pour la preparation de derives de 1-sulfo-2-oxoazetidine
FR2517308B1 (fr) Procede de preparation de derives de 3-alcoxymethylcephalosporines
BE865653A (fr) Procede pour la preparation de derives de diazepine
FR2499983B1 (fr) Procede de preparation de disulfures de thiurame
BE851983A (fr) Procede de preparation de cephalosporines
PT73284A (fr) Procede de preparation de derives de cephalosporines sulfoxides
FR2522662B1 (fr) Procede de preparation de cephalosporines
NL8400702A (nl) Werkwijze voor de bereiding van carbapenemderivaten.
RO80662A (ro) Procedeu pentru prepararea unor derivati de tiazol
FR2511681B1 (fr) Procede pour la preparation de derives de 3-exo-methylenecephame
MA18772A1 (fr) Procede de preparation de derives de benzothiazole
FR2505820B1 (fr) Procede de preparation de derives de (7e-9z)-alcadienols
BE882356A (fr) Procede de preparation de sulfoxydes de penicilline
BE877884A (fr) Procede de preparation de derives de cepheme
PT69288A (fr) Procede de preparation de derives benzylideniques
BE876539A (fr) Procede de preparation de cephalosporines
BE890748A (fr) Procede de preparation de derives de 11-dedecen-1-yle
FR2535314B1 (fr) Procede de preparation de derives de 2-cyclopentenone
PT71444A (fr) Procede pour la preparation de derives de benzimydazole
BE894591A (fr) Procede de preparation de derives thiosulfenamides de n-phosphonomethyglycinonitriles